Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Prostatic Neoplasms 4Breast Neoplasms 4Neoplasms 3Leiomyoma 2Vomiting 1Polycystic Ovary Syndrome 1Peripheral Nervous System Diseases 1Periampullary Carcinoma Nos 1Pediatric Crohn's disease 1Pain 1Obesity 1Nausea 1Myasthenia Gravis 1Motor Activity 1Menstruation Disturbances 1Memory Disorders 1Hyperinsulinism 1Hyperandrogenism 1Hot Flashes 1Fatigue 1Cognitive Dysfunction 1Cancer Pain 1Anemia 1

Interventions

Glutamine 2glutamic acid diethyl ester 1Sugars 1Sodium Selenite 1Sodium Chloride 1Saline Solution 1Paclitaxel 1Omeprazole 1N,N'-bis(pyridoxal-5-phosphate)ethylenediamine-N,N'-diacetic acid 1Ketamine 1Glutamic Acid 1Duloxetine Hydrochloride 1Drug Therapy 1Doxorubicin 1Dexamethasone 1Cyclophosphamide 1Carboplatin 1Bortezomib 1Bevacizumab 1Amifostine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Peripheral Nervous System Diseases × Sugars × Clear all
NCT00195013 2018-06-06

Randomized Placebo-Controlled Trial of Glutamine for Breast Cancer Patients With Peripheral Neuropathy

Weill Medical College of Cornell University

Phase 3 Completed
30 enrolled 5 charts
Breast

Breast Neoplasms, Peripheral Nervous System Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡